Published in Diabetes on March 01, 1995
Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A (2007) 3.11
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One (2008) 1.67
ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J (1996) 1.59
Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol (2010) 1.38
Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes (2009) 1.27
Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest (1996) 1.03
Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin. Clin Exp Immunol (2007) 0.95
A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes. Clin Immunol (2016) 0.92
T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient. Proc Natl Acad Sci U S A (1996) 0.89
Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation. Clin Exp Immunol (2009) 0.89
TSG-6 protein expression in the pancreatic islets of NOD mice. J Mol Histol (2008) 0.82
Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia. BMC Med Genet (2009) 0.78
Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients. Clin Exp Immunol (2000) 0.76
Autoimmune diabetes: ongoing development of immunological intervention strategies targeted directly against autoreactive T cells. Rev Diabet Stud (2004) 0.75
Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet (1997) 4.77
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med (2001) 3.85
Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med (1991) 3.41
Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature (1986) 2.59
Myosin VI isoform localized to clathrin-coated vesicles with a role in clathrin-mediated endocytosis. EMBO J (2001) 2.57
HLA-linked genetic control of host response to Mycobacterium leprae. Lancet (1976) 2.45
Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43
Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest (1987) 2.09
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature (1988) 2.07
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01
Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG. Infect Immun (1988) 2.01
Insulin release: the fuel hypothesis. Metabolism (1979) 1.84
Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia (2009) 1.70
Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature (1986) 1.69
Urinary creatinine excretion and lean body mass. Am J Clin Nutr (1976) 1.66
Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem J (1983) 1.65
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem (1996) 1.64
T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature (1990) 1.64
The internal pH and membrane potential of the insulin-secretory granule. Biochem J (1982) 1.59
The stimulus-secretion coupling of glucose-induced insulin release. Effect of exogenous pyruvate on islet function. Biochem J (1978) 1.52
Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes (1999) 1.52
The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events. Diabetologia (1979) 1.52
Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet (2000) 1.52
Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48
Cathepsin B-related proteases in the insulin secretory granule. J Biol Chem (1984) 1.47
Increasing incidence of type I diabetes in The Netherlands. The second nationwide study among children under 20 years of age. Diabetes Care (1994) 1.47
Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet (1986) 1.43
A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science (1988) 1.42
Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes (1999) 1.39
Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. Semin Cell Dev Biol (2000) 1.38
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
The midgestational human fetal pancreas contains cells coexpressing islet hormones. Dev Biol (1992) 1.37
The stimulus-secretion coupling of glucose-induced insulin release. Metabolic effects of menadione in isolated islets. Eur J Biochem (1978) 1.36
Isolation and characterisation of insulin secretory granules from a rat islet cell tumour. Diabetologia (1982) 1.36
Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. J Biol Chem (1992) 1.34
Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum (1990) 1.33
The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem J (1987) 1.33
HLA class II association with rheumatoid arthritis: facts and interpretations. Hum Immunol (2000) 1.32
Regulation of the biosynthesis of insulin-secretory-granule proteins. Co-ordinate translational control is exerted on some, but not all, granule matrix constituents. Biochem J (1989) 1.32
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30
Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation. Diabet Med (2008) 1.29
Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem (2001) 1.28
Genetic control of survival in epidemics. J Immunogenet (1979) 1.28
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet (1991) 1.26
Dynamics of O2 consumption in rat pancreatic islets. Diabetologia (1980) 1.24
Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Diabetologia (2007) 1.23
Regulation of calcium fluxes and their regulatory roles in pancreatic islets. Ann N Y Acad Sci (1978) 1.23
HLA association with autoimmune disease: a failure to protect? Rheumatology (Oxford) (2000) 1.22
Secretory-granule dynamics visualized in vivo with a phogrin-green fluorescent protein chimaera. Biochem J (1998) 1.22
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2000) 1.20
Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab (2010) 1.19
HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol (1983) 1.19
A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase. Biochem J (1992) 1.19
Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients. J Exp Med (1988) 1.18
Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients. J Exp Med (1986) 1.18
Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes (1996) 1.17
Proteolytic conversion of proinsulin into insulin. Identification of a Ca2+-dependent acidic endopeptidase in isolated insulin-secretory granules. Biochem J (1987) 1.16
Proton-translocating Mg2+-dependent ATPase activity in insulin-secretory granules. Biochem J (1982) 1.15
Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J Mol Endocrinol (2002) 1.14
Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis (1986) 1.14
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J Immunol (1994) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Production and characterization of monoclonal antibodies to insulin secretory granule membranes. Biochem J (1987) 1.13
Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis. Oncogene (2009) 1.12
The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A (1997) 1.12
Microcephaly and simplified gyral pattern of the brain associated with early onset insulin-dependent diabetes mellitus. Neurogenetics (2006) 1.12
Isolation and characterization of calmodulin from an insulin-secreting tumour. Biochem J (1981) 1.12
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol (1999) 1.11
Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant (2008) 1.11
HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol (1996) 1.11
Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin-thioredoxin reductase gene. Infect Immun (1997) 1.10
Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia (2009) 1.10
The stimulus-secretion coupling of amino acid-induced insulin release: metabolism and cationic effects of leucine. Diabetes (1980) 1.10
HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ. Hum Immunol (1985) 1.10
Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci U S A (1998) 1.10
High antigen reactivity in mononuclear cells from sites of chronic inflammation. Lancet (1990) 1.08
Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia (2008) 1.08
A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol (1993) 1.08
The stimulus secretion coupling of glucose-induced insulin release. XXVII. Effect of glucose on K+ fluxes in isolated islets. Pflugers Arch (1978) 1.07
IDA-1, a Caenorhabditis elegans homolog of the diabetic autoantigens IA-2 and phogrin, is expressed in peptidergic neurons in the worm. J Comp Neurol (2001) 1.07
Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol (1994) 1.07
Calcium antagonists and islet function: VII. Effect of calcium deprivation. J Membr Biol (1978) 1.07